United Kingdom
Reshoring from
Reshored business function
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations

66 jobs
Number of planned job creations
Job creation
Announcement Date
19 June 2014
Employment effect (start)
1 January 2014
Foreseen end date
1 December 2017


Bee Health is a British company based in East Yorkshire. The company produces pills, tablets and capsules. Bee Health has won £15m of contracts to backshore work previously based in China, India and the US. The company plans to offer better quality and flexibility of supply by producing tablets and soft gel capsules in the UK, creating 130 jobs. Holland & Barrett, one of the most important customers for Bee Health, and an high street retailer of alternative remedies, cited local sourcing as important to boost supply chain efficiencies and help it react quickly to market demand. Steve Ryan, managing director, said that new contracts would account for 70 per cent of turnover in 2014. The company has already hired 60 new staff, taking the workforce to 130, and a further 70 will be recruited by the end of 2014. Ryan added that although the company manufactures own-brand products, pretty much all of the new contracts will be completed under licence to other global customers who had been manufacturing in low-cost countries. These organisations have experienced gradual rises in costs, disruption in supply and unmanageable lead times. This has caused some clients to hold millions of pounds of stock at any one time, something that really impacts on cash flow.



Eurofound (2014), Bee Health, Reshoring in United Kingdom, factsheet number 184, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/184.